Maravai (MRVI) Schedule 13G: >5% Stake Then Below Threshold
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Maravai LifeSciences Holdings, Inc. Schedule 13G shows that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander reported acquiring beneficial ownership of more than 5% of the Class A common stock on 06/23/2026, and state they ceased to be beneficial owners of more than 5% by the date of this filing. The cover data lists 6,900,258 shares associated with shared voting and dispositive power, representing 4.7% of the class as reported on the cover pages. A Joint Filing Agreement dated 06/26/2026 is attached and the filing is signed by Gil Raviv and Israel A. Englander.
Insights
Report documents transient >5% ownership and shared control of 6,900,258 shares.
The filing states the reporting persons acquired beneficial ownership in excess of 5% on 06/23/2026 and subsequently ceased to exceed that threshold by the filing date; the cover pages show shared voting and shared dispositive power over 6,900,258 shares (listed as 4.7% of the class).
Disclosure is accompanied by a Joint Filing Agreement dated 06/26/2026. Cash-flow treatment and the specific transactions that reduced holdings below 5% are not described in the excerpt; future filings would show transaction mechanics if material.
Key Figures
Key Terms
beneficially owned regulatory
Joint Filing Agreement legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Schedule 13G for MRVI report?
Who signed the Schedule 13G for MRVI?
Does the filing describe how the >5% position was reduced?
AI-generated analysis. How Rhea-AI works. Not financial advice.